A single molecular descriptor to predict solution behavior of therapeutic antibodies
- PMID: 32923611
- PMCID: PMC7457339
- DOI: 10.1126/sciadv.abb0372
A single molecular descriptor to predict solution behavior of therapeutic antibodies
Abstract
Despite the therapeutic success of monoclonal antibodies (mAbs), early identification of developable mAb drug candidates with optimal manufacturability, stability, and delivery attributes remains elusive. Poor solution behavior, which manifests as high solution viscosity or opalescence, profoundly affects the developability of mAb drugs. Using a diverse dataset of 59 mAbs, including 43 approved products, and an array of molecular descriptors spanning colloidal, conformational, charge-based, hydrodynamic, and hydrophobic properties, we show that poor solution behavior is prevalent (>30%) in mAbs and is singularly predicted (>90%) by the diffusion interaction parameter (k D), a dilute-solution measure of colloidal self-interaction. No other descriptor, individually or in combination, was found to be as effective as k D. We also show that well-behaved mAbs, a substantial subset of which bear high positive charge and pI, present no disadvantages with respect to pharmacokinetics in humans. Here, we provide a systematic framework with quantitative thresholds for selecting well-behaved therapeutic mAbs during drug discovery.
Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).
Figures
References
-
- Walsh G., Biopharmaceutical benchmarks 2018. Nat. Biotechnol. 36, 1136–1145 (2018). - PubMed
-
- Casadevall A., Dadachova E., Pirofski L.-a., Passive antibody therapy for infectious diseases. Nat. Rev. Microbiol. 2, 695–703 (2004). - PubMed
-
- Carter P. J., Potent antibody therapeutics by design. Nat. Rev. Immunol. 6, 343–357 (2006). - PubMed
-
- Anselmo A. C., Gokarn Y., Mitragotri S., Non-invasive delivery strategies for biologics. Nat. Rev. Drug Discov. 18, 19–40 (2019). - PubMed
-
- Shire S. J., Shahrokh Z., Liu J., Challenges in the development of high protein concentration formulations. J. Pharm. Sci. 93, 1390–1402 (2004). - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
